3 Numbers From Viking Therapeutics' Weight-Loss Drug Trial That Have Wall Street Buzzing
The company continues to make good progress with its key obesity treatment drug, VK2735.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.